This creates a similar 5mg/mL concentration
Retatrutide dosing schedule Retatrutide dosage in clinical trials A phase 1 clinical trial of retatrutide involved 72 individuals with diagnosed type 2 diabetes who received 12 mg once weekly retatrutide injections subcutaneously for 12 weeks
These treatments potential to improve liver health and address comorbid conditions like obesity and diabetes supports their inclusion in a comprehensive treatment approach
The atomic coordinates and electron microscopy maps have been deposited in the Protein Data Bank (PDB) under accession codes: 7FIY (tirzepatideGIPRG s complex), 7VAB (non-acylated tirzepatideGIPRG s complex), 7FIM (tirzepatideGLP-1RG s complex), 7VBI (non-acylated tirzepatideGLP-1RG s complex), 7FIN (peptide 20GIPRG s complex), 7VBH (peptide 20GLP-1RG s complex) and 7V35 (peptide 20GCGRG s complex), as well as Electron Microscopy Data Bank (EMDB) under accession codes: EMD-31606 (tirzepatideGIPRG s complex), EMD-31836 (non-acylated tirzepatideGIPRG s complex), EMD-31603 (tirzepatideGLP-1RG s complex), EMD-31880 (non-acylated tirzepatideGLP-1RG s complex), EMD-31604 (peptide 20GIPRG s complex), EMD-31879 (peptide 20GLP-1RG s complex) and EMD-31676 (peptide 20GCGRG s complex), respectively
